sistem Absorbi lichid ce inseamna la markeri endocrini 9 32 ceară Antecedent Eradica
IJMS | Free Full-Text | Morphogen Signals Shaping the Gastric Glands in Health and Disease
Nitrate: An Environmental Endocrine Disruptor? A Review of Evidence and Research Needs | Environmental Science & Technology
Markeri tumorali in bolile digestive 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti | 0758751841 Cabinet privat de gastroenterologie si hepatologie Bucuresti
The neuropeptide landscape of human prefrontal cortex | PNAS
Hypercalcitoninemia in non-medullary thyroid carcinoma conditions | Download Table
Children | Free Full-Text | What Is New on Paediatric Echocardiography for the Diagnosis, Management and Follow-Up of the Multisystem Inflammatory Syndrome Associated with COVID-19?
Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer | NEJM
Use of Chicken Embryo Model in Toxicity Studies of Endocrine-Disrupting Chemicals and Nanoparticles | Chemical Research in Toxicology
Role of Macrophages in the Endocrine System: Trends in Endocrinology & Metabolism
Frontiers | Interplay Between the Immune and Endocrine Systems in the Lung: Implications for TB Susceptibility
Characterization and reduction of non-endocrine cells accompanying islet-like endocrine cells differentiated from human iPSC | Scientific Reports
ISX-9 manipulates endocrine progenitor fate revealing conserved intestinal lineages in mouse and human organoids - ScienceDirect
Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored By American Association of Clinical Endocrinologists/American College of ...
Frontiers | Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial - The Lancet Oncology
Consensus on diagnosis and management of Cushing's disease: a guideline update - The Lancet Diabetes & Endocrinology